Korfhage L, Broghamer W L, Richardson M E, Parker J E, Gilkey C M
Acta Cytol. 1986 Jul-Aug;30(4):351-5.
A study of 113 patients with histologically confirmed bronchogenic carcinoma and survival for at least 18 months was performed. Posttherapeutic cytologic specimens were submitted for only 52.2% (59/113), and for only 8.5% (5/59) of the individuals was specimen procurement related to clinic visits. Yet, when utilized as a diagnostic procedure for the hospitalized patient, a positive cytodiagnosis was made on 55.6% (15/27) of the patients with recurrent carcinoma, in 61.1% (11/18) with persistent disease and in all 5 patients with a metachronous primary bronchogenic carcinoma. Cytologic diagnoses of cancer compared favorably with concurrent histologic interpretations of biopsies and radiologic observations of chest films.
对113例经组织学确诊为支气管源性癌且存活至少18个月的患者进行了一项研究。仅52.2%（59/113）的患者提交了治疗后的细胞学标本，其中仅8.5%（5/59）的个体的标本采集与门诊就诊有关。然而，当作为住院患者的诊断程序使用时，复发性癌患者中有55.6%（15/27）、持续性疾病患者中有61.1%（11/18）以及所有5例异时性原发性支气管源性癌患者均做出了阳性细胞诊断。癌症的细胞学诊断与活检的同期组织学解释及胸部X光片的放射学观察结果相比具有优势。
